Literature DB >> 18588573

Fas promoter polymorphisms: genetic predisposition to sarcoidosis in African-Americans.

Y S Wasfi1, L J Silveira, A Jonth, J E Hokanson, T Fingerlin, H Sato, C E Parsons, P Lympany, K Welsh, R M du Bois, L S Newman, L A Maier.   

Abstract

Apoptosis may perpetuate some forms of inflammation. Of the apoptotic pathway proteins, Fas is particularly overexpressed in sarcoidosis. We hypothesized that Fas promoter single nucleotide polymorphisms (SNPs) contribute to the development and severity of sarcoidosis. Associations of known Fas promoter SNPs (-670, -690 and -1377) and deduced haplotypes with sarcoidosis and sarcoidosis severity were evaluated using matched case-control (n = 656 pairs) and case-comparison (n = 656) studies, respectively, using conditional logistic regression. Hardy-Weinberg equilibrium was confirmed for all three polymorphisms in African-Americans (AA), and for the -670 and -1377 in whites. Genotype and allele frequencies were significantly different between whites and AA. Race-stratified analysis revealed that a common haplotype, -1377G/-690T/-670G, was associated with sarcoidosis [odds ratio (OR) = 1.78, P = 0.05] only in AA. The haplotype -1377G/-690C/-670A was negatively associated with sarcoidosis (OR = 0.39, P = 0.03) only in AA. In conclusion, the consistency of these findings suggests that Fas promoter genetic variants may be related to sarcoidosis disease risk in AA.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18588573      PMCID: PMC3061555          DOI: 10.1111/j.1399-0039.2008.01060.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  28 in total

Review 1.  Molecular typing for the MHC with PCR-SSP.

Authors:  K Welsh; M Bunce
Journal:  Rev Immunogenet       Date:  1999

2.  The FAS-670 polymorphism influences susceptibility to multiple sclerosis.

Authors:  T van Veen; N F Kalkers; J B A Crusius; L van Winsen; F Barkhof; P J H Jongen; A S Peña; C H Polman; B M J Uitdehaag
Journal:  J Neuroimmunol       Date:  2002-07       Impact factor: 3.478

3.  A polymorphism in FAS gene promoter correlated with circulating soluble FAS levels.

Authors:  W Mahfoudh; B Bel Hadj Jrad; A Romdhane; L Chouchane
Journal:  Int J Immunogenet       Date:  2007-06       Impact factor: 1.466

4.  Clinical characteristics of patients in a case control study of sarcoidosis.

Authors:  R P Baughman; A S Teirstein; M A Judson; M D Rossman; H Yeager; E A Bresnitz; L DePalo; G Hunninghake; M C Iannuzzi; C J Johns; G McLennan; D R Moller; L S Newman; D L Rabin; C Rose; B Rybicki; S E Weinberger; M L Terrin; G L Knatterud; R Cherniak
Journal:  Am J Respir Crit Care Med       Date:  2001-11-15       Impact factor: 21.405

5.  Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS).

Authors:  B A Rybicki; M C Iannuzzi; M M Frederick; B W Thompson; M D Rossman; E A Bresnitz; M L Terrin; D R Moller; J Barnard; R P Baughman; L DePalo; G Hunninghake; C Johns; M A Judson; G L Knatterud; G McLennan; L S Newman; D L Rabin; C Rose; A S Teirstein; S E Weinberger; H Yeager; R Cherniack
Journal:  Am J Respir Crit Care Med       Date:  2001-12-01       Impact factor: 21.405

6.  Results from a genome-wide search for predisposing genes in sarcoidosis.

Authors:  M Schürmann; P Reichel; B Müller-Myhsok; M Schlaak; J Müller-Quernheim; E Schwinger
Journal:  Am J Respir Crit Care Med       Date:  2001-09-01       Impact factor: 21.405

7.  Beryllium induces apoptosis in human lung macrophages.

Authors:  Lori A Kittle; Richard T Sawyer; Valerie A Fadok; Lisa A Maier; Lee S Newman
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2002-06       Impact factor: 0.670

8.  HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites.

Authors:  Milton D Rossman; Bruce Thompson; Margaret Frederick; Mary Maliarik; Michael C Iannuzzi; Benjamin A Rybicki; Janardan P Pandey; Lee S Newman; Eleni Magira; Bojana Beznik-Cizman; Dimitri Monos
Journal:  Am J Hum Genet       Date:  2003-08-20       Impact factor: 11.025

9.  HLA-DQB1*0201: a marker for good prognosis in British and Dutch patients with sarcoidosis.

Authors:  Hiroe Sato; Jan C Grutters; Panagiotis Pantelidis; A Neil Mizzon; Tariq Ahmad; Arend-Jan Van Houte; Jan-Willem J Lammers; Jules M M Van Den Bosch; Kenneth I Welsh; Roland M Du Bois
Journal:  Am J Respir Cell Mol Biol       Date:  2002-10       Impact factor: 6.914

10.  A functional polymorphism in fas (CD95/APO-1) gene promoter associated with systemic lupus erythematosus.

Authors:  Satomi Kanemitsu; Kenji Ihara; Ahmed Saifddin; Takeshi Otsuka; Tsutomu Takeuchi; Jun Nagayama; Michihiko Kuwano; Toshiro Hara
Journal:  J Rheumatol       Date:  2002-06       Impact factor: 4.666

View more
  3 in total

1.  The FAS -670A>G polymorphism influences susceptibility to systemic sclerosis phenotypes.

Authors:  J Broen; P Gourh; B Rueda; M Coenen; M Mayes; J Martin; F C Arnett; T R D J Radstake
Journal:  Arthritis Rheum       Date:  2009-12

2.  APO-1/Fas gene: Structural and functional characteristics in systemic lupus erythematosus and other autoimmune diseases.

Authors:  Richa Singh; Vandana Pradhan; Manisha Patwardhan; K Ghosh
Journal:  Indian J Hum Genet       Date:  2009-09

3.  Impaired survival of regulatory T cells in pulmonary sarcoidosis.

Authors:  Caroline E Broos; Menno van Nimwegen; Alex Kleinjan; Bregje ten Berge; Femke Muskens; Johannes C C M in 't Veen; Jouke T Annema; Bart N Lambrecht; Henk C Hoogsteden; Rudi W Hendriks; Mirjam Kool; Bernt van den Blink
Journal:  Respir Res       Date:  2015-09-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.